A Case of Hypersexuality in a Patient Receiving Aripiprazole for Schizophrenia

Aripiprazole is an antipsychotic with partial agonist activity at the dopamine D2 receptor which may lead to compulsive behaviors including hypersexuality. The case presented is of a 24-year-old male with schizophrenia who developed hypersexuality symptoms after initiation of aripiprazole. Cessation...

Descripción completa

Detalles Bibliográficos
Autores principales: Priya, Lakshmi, Moorthy, Bini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249151/
https://www.ncbi.nlm.nih.gov/pubmed/34258097
http://dx.doi.org/10.1155/2021/5557211
_version_ 1783716851773079552
author Priya, Lakshmi
Moorthy, Bini
author_facet Priya, Lakshmi
Moorthy, Bini
author_sort Priya, Lakshmi
collection PubMed
description Aripiprazole is an antipsychotic with partial agonist activity at the dopamine D2 receptor which may lead to compulsive behaviors including hypersexuality. The case presented is of a 24-year-old male with schizophrenia who developed hypersexuality symptoms after initiation of aripiprazole. Cessation of the aripiprazole led to a reduction in hypersexual behaviors. Clinicians should be aware of compulsive behaviors including hypersexuality with aripiprazole use and consider discontinuation of aripiprazole treatment in patients suffering from hypersexuality.
format Online
Article
Text
id pubmed-8249151
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-82491512021-07-12 A Case of Hypersexuality in a Patient Receiving Aripiprazole for Schizophrenia Priya, Lakshmi Moorthy, Bini Case Rep Psychiatry Case Report Aripiprazole is an antipsychotic with partial agonist activity at the dopamine D2 receptor which may lead to compulsive behaviors including hypersexuality. The case presented is of a 24-year-old male with schizophrenia who developed hypersexuality symptoms after initiation of aripiprazole. Cessation of the aripiprazole led to a reduction in hypersexual behaviors. Clinicians should be aware of compulsive behaviors including hypersexuality with aripiprazole use and consider discontinuation of aripiprazole treatment in patients suffering from hypersexuality. Hindawi 2021-06-24 /pmc/articles/PMC8249151/ /pubmed/34258097 http://dx.doi.org/10.1155/2021/5557211 Text en Copyright © 2021 Lakshmi Priya and Bini Moorthy. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Priya, Lakshmi
Moorthy, Bini
A Case of Hypersexuality in a Patient Receiving Aripiprazole for Schizophrenia
title A Case of Hypersexuality in a Patient Receiving Aripiprazole for Schizophrenia
title_full A Case of Hypersexuality in a Patient Receiving Aripiprazole for Schizophrenia
title_fullStr A Case of Hypersexuality in a Patient Receiving Aripiprazole for Schizophrenia
title_full_unstemmed A Case of Hypersexuality in a Patient Receiving Aripiprazole for Schizophrenia
title_short A Case of Hypersexuality in a Patient Receiving Aripiprazole for Schizophrenia
title_sort case of hypersexuality in a patient receiving aripiprazole for schizophrenia
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249151/
https://www.ncbi.nlm.nih.gov/pubmed/34258097
http://dx.doi.org/10.1155/2021/5557211
work_keys_str_mv AT priyalakshmi acaseofhypersexualityinapatientreceivingaripiprazoleforschizophrenia
AT moorthybini acaseofhypersexualityinapatientreceivingaripiprazoleforschizophrenia
AT priyalakshmi caseofhypersexualityinapatientreceivingaripiprazoleforschizophrenia
AT moorthybini caseofhypersexualityinapatientreceivingaripiprazoleforschizophrenia

Ejemplares similares